Armata Pharmaceuticals Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.48

+0.02 (+0.31%)

As of Jul 4, 2:05 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +169.3% upside

Low Target $10.78

Average Target $17.45

High Target $19.60

Current Price $6.48

Current
$6.48

Target
$17.45

$10.78 $17.45 avg $19.60

Scenario Analysis

Bear Case

$10.78

66.4%

Low target

Base Case

$17.45

+169.3%

Avg target

Bull Case

$19.60

+202.5%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$16.34

-60.3% from high

52-Week Low

$1.91

+239.3% from low

Target vs 52W High

$17.45

+6.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	-1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-49.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+176.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-88.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-67.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.8%